Previous 10 | Next 10 |
BOULDER, Colo., March 01, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the fourth quarter and full year 2021 after market close on Tuesday, March 29, 2022. Company management will host a...
BOULDER, Colo., Feb. 25, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the Cowen 42nd Annual Health Care Conference. SomaLogic management is scheduled to participate in a fireside c...
The following slide deck was published by SomaLogic, Inc. in conjunction with this event. For further details see: SomaLogic (SLGC) Investor Presentation - Slideshow
SomaLogic (NASDAQ:SLGC) stated Friday that it expects its FY22 revenue to range between $105-$110M vs. consensus of $103.45M. "We are growing the size of our commercial team substantially and diversifying our unique offerings for our customers and collaborators. These successful efforts, alon...
BOULDER, Colo., Feb. 04, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, will host a virtual analyst and investor meeting today, February 4 th , 2022, from 10:00 a.m. to approximately 1:00 p.m. Eastern Time. The event is intended to highlight ...
BOULDER, Colo., Feb. 02, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the following virtual investor conferences. BTIG MedTech, Digital Health, Life Science & Diagnostic Tool...
BOULDER, Colo., Feb. 02, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that the company will begin assaying samples from the Multi-Ethnic Study of Atherosclerosis (MESA) study beginning in the first quarter of 2022. SomaLog...
BOULDER, Colo., Jan. 11, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced preliminary, unaudited revenue expectations for the year ending December 31 st , 2021. Preliminary, unaudited revenue for the full year 2021 is expe...
BOULDER, Colo., Jan. 10, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Adam Taich has joined the company as the Chief Business Officer. In this newly created role, Adam will have broad responsibility across SomaL...
BOULDER, Colo., Jan. 07, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, will host a virtual Analyst and Investor Meeting on Friday, February 4, 2022, beginning at 10:00 a.m. Eastern Time. The virtual event will feature presentations from company ...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health , today announced that its stockholders voted to approve all proposals required to be approved in...
SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting PR Newswire Stockholder Approval Represents Key Milestone Toward Completion of Standard BioTools Transaction Combination Will Create a Diversified Leader in Life Sciences Tools ...
Believes All SomaLogic Directors – Robert Barchi , Thomas Carey , Eli Casdin , Troy Cox , Kathy Hibbs , Anne Margulies , Tycho Peterson , Richard Post and Jason Ryan – Have Betrayed Shareholders by Delaying the Special Meeting Five Times so the Bo...